161 related articles for article (PubMed ID: 7793888)
1. Susceptibilities of Chlamydia trachomatis isolates causing uncomplicated female genital tract infections and pelvic inflammatory disease.
Rice RJ; Bhullar V; Mitchell SH; Bullard J; Knapp JS
Antimicrob Agents Chemother; 1995 Mar; 39(3):760-2. PubMed ID: 7793888
[TBL] [Abstract][Full Text] [Related]
2. Association of the in vitro susceptibility of clinical isolates of chlamydia trachomatis with serovar and duration of antibiotic exposure.
Zheng H; Xue Y; Bai S; Qin X; Lu P; Yang B
Sex Transm Dis; 2015 Mar; 42(3):115-9. PubMed ID: 25668641
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infections.
Pitt R; Alexander S; Ison C; Horner P; Hathorn E; Goold P; Woodford N; Cole MJ
J Antimicrob Chemother; 2018 Mar; 73(3):680-686. PubMed ID: 29207004
[TBL] [Abstract][Full Text] [Related]
4. High treatment failure rate is better explained by resistance gene detection than by minimum inhibitory concentration in patients with urogenital Chlamydia trachomatis infection.
Shao L; You C; Cao J; Jiang Y; Liu Y; Liu Q
Int J Infect Dis; 2020 Jul; 96():121-127. PubMed ID: 32173573
[TBL] [Abstract][Full Text] [Related]
5. Lack of evidence of a relationship between genital symptoms, cervicitis and salpingitis and different serovars of Chlamydia trachomatis.
Persson K; Osser S
Eur J Clin Microbiol Infect Dis; 1993 Mar; 12(3):195-9. PubMed ID: 8508818
[TBL] [Abstract][Full Text] [Related]
6. Clinical manifestations of genital infection due to Chlamydia trachomatis in women: differences related to serovar.
Workowski KA; Stevens CE; Suchland RJ; Holmes KK; Eschenbach DA; Pettinger MB; Stamm WE
Clin Infect Dis; 1994 Oct; 19(4):756-60. PubMed ID: 7803644
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae.
Agacfidan A; Moncada J; Schachter J
Antimicrob Agents Chemother; 1993 Sep; 37(9):1746-8. PubMed ID: 8239579
[TBL] [Abstract][Full Text] [Related]
8. Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India.
Bhengraj AR; Vardhan H; Srivastava P; Salhan S; Mittal A
Chemotherapy; 2010; 56(5):371-7. PubMed ID: 20938174
[TBL] [Abstract][Full Text] [Related]
9. Chlamydia trachomatis: impact on human reproduction.
Paavonen J; Eggert-Kruse W
Hum Reprod Update; 1999; 5(5):433-47. PubMed ID: 10582782
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of five different antibiotic regimens for the treatment of uncomplicated Chlamydia trachomatis cervicitis.
Nuovo J; Melnikow J; Paliescheskey M; King J; Mowers R
J Am Board Fam Pract; 1995; 8(1):7-16. PubMed ID: 7701965
[TBL] [Abstract][Full Text] [Related]
11. Chlamydia trachomatis: in vitro susceptibility of genital and ocular isolates to some quinolones, amoxicillin and azithromycin.
Børsum T; Dannevig L; Størvold G; Melby K
Chemotherapy; 1990; 36(6):407-15. PubMed ID: 1963393
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of urogenital Chlamydia trachomatis strains in a country with high azithromycin consumption rate.
Ljubin-Sternak S; Mestrovic T; Vilibic-Cavlek T; Mlinaric-Galinovic G; Sviben M; Markotic A; Skerk V
Folia Microbiol (Praha); 2013 Sep; 58(5):361-5. PubMed ID: 23271498
[TBL] [Abstract][Full Text] [Related]
13. Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan.
Takahashi S; Hamasuna R; Yasuda M; Ishikawa K; Hayami H; Uehara S; Yamamoto S; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sato J; Hanaki H; Masumori N; Kiyota H; Egawa S; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Wada K; Kobayashi K; Matsubara A; Matsumoto T; Eto M; Tatsugami K; Kuroiwa K; Ito K; Hosobe T; Hirayama H; Narita H; Yamaguchi T; Ito S; Sumii T; Kawai S; Kanokogi M; Kawano H; Chokyu H; Uno S; Monden K; Kaji S; Kawahara M; Takayama K; Ito M; Yoshioka M; Kano M; Konishi T; Kadena H; Nishi S; Nishimura H; Yamauchi T; Maeda S; Horie M; Ihara H; Matsumura M; Shirane T; Takeyama K; Akiyama K; Takahashi K; Ikuyama T; Inatomi H; Yoh M
J Infect Chemother; 2016 Sep; 22(9):581-6. PubMed ID: 27452428
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines.
Samra Z; Rosenberg S; Soffer Y; Dan M
Diagn Microbiol Infect Dis; 2001 Mar; 39(3):177-9. PubMed ID: 11337185
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibilities of Chlamydia trachomatis isolated from the urethra and pharynx of Japanese males.
Kai S; Wada K; Sadahira T; Araki M; Ishii A; Watanabe T; Monden K; Uno S; Araki T; Nasu Y
J Infect Chemother; 2017 Aug; 23(8):512-516. PubMed ID: 28476331
[TBL] [Abstract][Full Text] [Related]
16. Effects of cationic liposome-encapsulated doxycycline on experimental Chlamydia trachomatis genital infection in mice.
Sangaré L; Morisset R; Gaboury L; Ravaoarinoro M
J Antimicrob Chemother; 2001 Mar; 47(3):323-31. PubMed ID: 11222565
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of azithromycin and doxycycline against 15 isolates of Chlamydia pneumoniae.
Gnarpe J; Eriksson K; Gnarpe H
Antimicrob Agents Chemother; 1996 Aug; 40(8):1843-5. PubMed ID: 8843291
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of Neisseria gonorrhoeae associated with pelvic inflammatory disease to cefoxitin, ceftriaxone, clindamycin, gentamicin, doxycycline, azithromycin, and other antimicrobial agents.
Rice RJ; Knapp JS
Antimicrob Agents Chemother; 1994 Jul; 38(7):1688-91. PubMed ID: 7979312
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis.
Roblin PM; Hammerschlag MR
Int J Antimicrob Agents; 2000 Sep; 16(1):61-3. PubMed ID: 11185415
[TBL] [Abstract][Full Text] [Related]
20. Differing effects of azithromycin and doxycycline on cytokines in cells from Chlamydia trachomatis-infected women.
Srivastava P; Bhengraj AR; Jha HC; Vardhan H; Jha R; Singh LC; Salhan S; Mittal A
DNA Cell Biol; 2012 Mar; 31(3):392-401. PubMed ID: 21848430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
